The ratio of post-infusion circulating PD-1+ CAR-T subsets to product PD-1+ CAR-T cells serves as a predictive biomarker for long-term disease control in CAR T-cell therapy for R/R B-cell lymphoma
Authors
Shilin Gan
Fan Yang (ORCID: https://orcid.org/0000-0002-0520-5254)
Kai Hu (ORCID: https://orcid.org/0000-0002-2777-9080)
Lixia Ma (ORCID: https://orcid.org/0009-0006-3403-3806)
Miaomiao Cao (ORCID: https://orcid.org/0000-0002-4863-4454)
Alex H. Zhang
Rui Liu (ORCID: https://orcid.org/0000-0001-7573-3346)
Xiaoyan Ke (ORCID: https://orcid.org/0009-0007-7526-3875)
Biping Deng (ORCID: https://orcid.org/0000-0002-3244-9174)
The ratio of post-infusion circulating PD-1+ CAR-T subsets to product PD-1+ CAR-T cells serves as a predictive biomarker for long-term disease control in CAR T-cell therapy for R/R B-cell lymphoma
Shilin Gan, Fan Yang, Kai Hu, Lixia Ma et al.
Journal
Blood
Topics
CAR-T cell therapy research
article
The ratio of post-infusion circulating PD-1+ CAR-T subsets to product PD-1+ CAR-T cells serves as a predictive biomarker for long-term disease control in CAR T-cell therapy for R/R B-cell lymphoma
Shilin Gan, Fan Yang, Kai Hu, Lixia Ma, Miaomiao Cao, Alex H. Zhang, Rui Liu, Xiaoyan Ke, Biping Deng, Zhonghua Fu, Yuelu Guo
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
Fudan University (CN), Cystic Fibrosis Trust (GB), Lymphoma Study Association (FR), Biostatistical Consulting (United States) (US)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
The ratio of post-infusion circulating PD-1+ CAR-T subsets to product PD-1+ CAR-T cells serves as a predictive biomarker for long-term disease control in CAR T-cell therapy for R/R B-cell lymphoma — Shilin Gan, Fan Yang, et al. · Blood (2025) | TGRS Research Map | TGRS